Leiden University Scholarly Publications

Persistent URL of this record https://hdl.handle.net/1887/81804

In Collections

This item can be found in the following collections:

Booij, T.H.; Price, L.S.; Danen, E.H.J. (2019)

3D Cell-Based Assays for Drug Screens: Challenges in Imaging, Image Analysis, and High-Content Analysis

Article / Letter to editor
The introduction of more relevant cell models in early preclinical drug discovery, combined with high-content imaging and automated analysis, is expected to increase the quality of compounds progressing to preclinical stages in the drug development pipeline. In this review we discuss the current switch to more relevant 3D cell culture models and associated challenges for high-throughput screening and high-content analysis. We propose that overcoming these challenges will enable front-loading the drug discovery pipeline with better biology, extracting the most from that biology, and, in general, improving translation between in vitro and in vivo models. This is expected to reduce the proportion of compounds that fail in vivo testing due to a lack of efficacy or to toxicity.
High-content screening
3D culture
Imaging
Image analysis
All authors
Booij, T.H.; Price, L.S.; Danen, E.H.J.
Date
2019-07-31
Journal
Slas Discovery
Volume
24
Issue
6
Pages
615 - 627
DOI
doi:10.1177/2472555219830087